The latest Transparency in Coverage Rules in Healthcare Pricing mandate the disclosure of price and cost-sharing information upfront to participants, beneficiaries, and enrollees. The rules aim to provide patients with accurate cost estimates, accessible price information, and standardized comparisons, shifting the focus to payers for transparency. Implementation of the rules spans from 2022 to 2024, emphasizing machine-readable files and patient-facing tools. Challenges include industry resistance, concerns about potential premium increases, and the need to modernize technology for effective transparency. The rules seek to address the complexity of healthcare costs and empower consumers to make informed decisions, ultimately aiming to reduce surprise bills and increase transparency in the healthcare pricing system.
Transcription
4625 Words, 27047 Characters
Hi, everyone. Welcome to this episode of 16 Minutes. I'm Sonal, your host, and we're
covering the latest Transparency in Coverage Rules in Healthcare Pricing, which affects
everyone. They've been in the works for a while, but the final ones were released a
few weeks ago by the Department of Health and Human Services, CMS, the Centers for
Medicare and Medicaid Services. So we not only break down what they are, but what both
consumers and various industry players need to know, including timing and practical considerations.
As Health Secretary Alex Azar observed, patients' healthcare conversations cannot take place,
quote, "in a shadowy system where prices are hidden." If you'd like to hear more about
this system more broadly, be sure to check out our show, Bioeats World, where we featured
a conversation on that with Surgeon Marty McAree, author of the book, The Price We Pay.
But in this episode, we dig into the specifics of these rules, as well as, as always, the
gap between what's hype, what's real, with our A6NC bio experts Justin Larkin and General
Partner Julie Yu. Julie has also covered on other past episodes' historic rules. They're
all described as historic, by the way, and you can find these in the show notes or at
asixnz.com/16minutes. To quickly summarize these rules at a high level, they will require
most employer group health plans and health insurance issuers to disclose price and cost-sharing
information to participants, beneficiaries, and enrollees up front. The goal is to give
patients accurate estimates of the costs that they are paying for, including making previously
unavailable price information accessible to them and other stakeholders in a standardized
way, allowing for easy comparisons and potential competition down the line.
So my first question for you guys, always the first question, is why does this matter?
What's a big picture here?
Yeah, so ballooning costs in healthcare is basically the headline of what the industry
has been focused on for decades. And, you know, the thing that has been controversial
is who is ultimately responsible for those high costs. And one of the things that's powerful
about this rule is that it is expressly pointing the finger at the hospitals and the insurance
companies who have been negotiating these contracts behind closed doors. I think from
a consumer lens, when we think about consuming services in the rest of our lives, our ability
to shop, our ability to have choice are all things that we sort of take for granted.
And this rule does set us on the path towards where we can shop for the best options and
be guaranteed that we won't be hit by surprise bills. On the other hand, it can be viewed
as a huge threat. Reimbursement is the tale that wags a dog in healthcare. The vast majority
of revenue that flows through our healthcare system is in the form of reimbursed revenue.
And to get into the game of healthcare, a lot of it is all about what kinds of contracts
can you negotiate with insurance companies. Hospitals clearly consider those contracts
their crown jewels. And this rule represents a really interesting paradox in healthcare,
which is the notion of a top-down mandate that compels business entities to disclose
the terms of what they would consider highly preparatory contracts is actually antithetical
in many ways to the way that efficient markets should work. And so I think that healthy attention
is going to be the source of much of the agitation that plays out with regards to this rule.
Yeah. In no other aspect of our financial lives, we ever imagined going and engaging
in a service where we didn't know the price and their unique aspects of healthcare that
are just different and require a higher level of transparency, things like the magnitude
of cost, the complexity of the cost sharing, there are deductibles or co-payments or co-insurances.
There's in-network, out-of-network. All of these things create this immensely challenging
environment for folks to make rational informed decisions. And then you add on top of that
the variability of the cost where I could go out and search for a completely commoditized
healthcare service and there could be a three, five, 10X swing and the price of that blocks
away from each other purely on the basis of some of the obscurity that's existed in the
healthcare system. This topic hits extremely close to home for us. We have a son that required
a major surgery, major ICU stay early on in his life. And after hearing a number of families
be nearly bankrupted from similar experiences, we try to get a sense of how much it would
cost. So we called our insurer, they couldn't give us a ballpark figure. So they referred
us to the hospital to get their financial services team to give us a perspective. They
couldn't give us a figure. They referred us back to the insurer. At the end, all we
knew is that we were expecting somewhere north of a million dollars, but we had no idea if
we would owe $500, $5,000, $150,000 at the end of it. And I just remember walking away
from this experience, just thinking, even as a physician, even as someone who spends
all day every day working in healthcare, even after spending hours and hours on the phone
with providers in our health plan, I couldn't get to an answer. Luckily, we ended up on
the better end of that spectrum, but there's something fun in a million wrong here.
Wow, there really is. And thank you for sharing that story, Justin, which is unfortunately
way, way too commonplace for many, many people. And not all of them even have the resources
or ability to kind of understand what's going on necessarily. They're from a different country.
Don't understand the language. There's all kinds of factors that play. Julie, you've
actually described some of these dynamics, the "dark art of payer contracts." The question
I have for you is why was it so hard for Justin to find that information out? Why is this such
a shadowy system where prices are hidden?
So a couple of things. One is that for a complex surgical encounter, like the one that Justin
described, there are legitimately a set of services that you may not anticipate you need
when a patient comes in, but it's even hard for hospitals to understand their cost structure
to begin with. The notion of even like cost-based accounting in any provider organization is
pretty rare that you hear that these organizations have a handle on exactly what it does cost
on a unit basis for a single service or a single procedure to be delivered. And there
just really hasn't been incentive to do that. The other aspect of these contracts is that
a lot of it is really predicated on market power. And you oftentimes hear hospitals compared
to cartels. You hear all about consolidation that's happened across the market, which is
actually ironically accelerated with the advent of value-based care being viewed as a threat
to the traditional fee-for-service revenue streams. A lot of the response to that has
been we got to aggregate more volume such that we can more aggressively negotiate with
insurance companies for higher prices. That's actually one of the major dynamics. The most
dominant hospitals in a given market do have a tremendous amount of leverage. And the combination
of that with a lack of clear understanding of their cost structure is a lot of what's
pushed those prices up.
Absolutely. The complexity of the cost structure of hospitals is a key piece of this. But one
of the other components, and this is where the earlier ruling on price transparency that
was hospital-centric somewhat came short, is that knowing the price that a given hospital
is going to charge to your insurance is only a piece of the puzzle. The other piece of
price transparency for consumers is what is your personal responsibility against that
price. And we've talked to a number of different health system partners who have wanted to
be able to provide upfront cost estimates for their patients. But there's this complexity
of where they have to interact with the payer to then understand, okay, what's this patient
specific deductible? What's their specific co-pay? How much have they already paid on
their deductible?
At the end of the day, it's the health plan and the insure that owns really the financial
relationship with the patient. There is obviously bills that will come from the health systems
themselves, but it's the health plan that determines how much they're going to pay the
health system.
And so I think what's elegant about this new final rule is that it really shifts the focus
to the payer, where they do have the transparency understanding of the price that they've negotiated
and where that individual is at in their journey. So they can say, this is the price and you've
already paid $400 in your deductible, so your responsibility is $600.
Yeah. I think it's notable to consider this rule in conjunction with the hospital rule,
pet gaps. One example was actually that the hospital rule specifically did not include
non-employed physicians in its mandate. And it's often the case that health systems,
their medical staff is actually sometimes largely comprised of just contractors or affiliate
providers who are not actually on the employed payroll of the hospital. And that's where
you see these examples of if I go in for a procedure, even if that facility and the main
surgeon on my case is in network with my insurance, there might be an anesthesiologist or some
other ancillary provider who's not. And that's really where those surprise bills comes in.
And so when you combine that with the insurance-oriented rule, that's where you get that air cover
and that coverage of all of these sort of corner cases that weren't explicitly addressed
by the hospital side of the equation.
What is the difference in price and cost? In my head, they're kind of intertwined and
quite confusing, in fact. It would help a lot to have you really break down the difference
between price and cost when it comes to the healthcare system.
Yeah. No, I mean, I feel the same way. The way that people use those terms is interchangeable,
where they're certainly not. And there are probably two legitimate interpretations of
price versus cost. So one is the cost to the hospital. So if I'm a provider providing
the service, like how much outlay do I need to make to actually even deliver the service?
That is a traditional definition of cost and cost structure in the business sense. Whereas
price in that case would be the price that I, the provider, charge to whomever will pay.
That could be a combination of the insurance and the individual consumer. So that would
be more of a traditional definition of price versus cost. Now, the way that cost is used
in certain clauses of this particular rule is actually the cost to the consumer. And
so that is the out-of-pocket cost, how much I as a consumer ultimately need to pay in
addition to any coverage that I get through my insurance company. And I think that's where
a lot of the confusion comes is that you're sort of using that term interchangeably in
two different scenarios. Price is a very, very important component of what needs to
have transparency. But cost is equally important. And a lot of the reason I would argue that
costs have ballooned out of control is negotiations between providers and insurance companies have
largely been price-driven. Marty talked about this on our podcast together. Hospitals inherently
assume that whatever price they put in front of an insurance company will immediately get
discounted and that they'll only essentially earn a small percentage of that. And so they
explicitly mark up the price that they put in front of the payer. And that just starts
as vicious cycle of back and forth that ultimately leads to higher and higher prices over time.
And by the way, I think the line he used in that podcast is sort of mark up, discount,
mark up, discount, mark up, discount, mark up, discount. That's the sound effect that
goes with that vicious cycle you just described. So now let's tease apart, as is the premise
of the show, what's hype, what's real? So first of all, I have to call BS, which is
you both said this, the rule said this, the coverage says this. Does this really truly
mean no surprise healthcare bills? It seems healthcare is way too complex to actually
guarantee that requirement. Can you guys help me tease apart what's hype, what's real there?
Yeah, it's a great question. And I think that's one of the dangers of any kind of price transparency
rule is you can get this false sense that, oh, I know all of my costs and then still get
surprised at the end of the day. Going back to Julie's point earlier, that was one of
the biggest challenges with the hospital-focused iteration of this. But what I will say is
that a payer-centric iteration of this gets a lot closer to solving that issue and that
not only does it capture some of those issues within network provider out of network provider
and what your coverage would be in each of those environments, but even it gets down
to being able to predict price against prescription medications and even things like durable medical
equipment. So a lot of these things that in the past could have driven a lot of unexpected
costs are now captured within the rule. The last piece is of the requirement for the health
plans to create a place where consumers could interact with that information. So it's not
just a PDF or a flat file sitting and some archive somewhere.
Basically what you're talking about is that out of network allowed machine-readable file
and the machine-readable file must include specific things, including billing code, amounts,
bill charges, et cetera. There's also prescription drug machine-readable file. They even outline
the specific things that each of those files have to include. Really glad you brought that
up.
The question becomes, in the implementation of this, are folks able to gather that data
and present it in a way that patients can internalize it and make decisions against it?
Because it's not just about having the data, but really putting it into practice.
And I would add there's a very important distinction between shoppable and non-shoppable services,
which is distinct from the concept of transparency. Because if you end up in the emergency room
and you had no control over what services were provided or needed, then any price will likely
be a surprise. It's also worth noting that there are a separate set of legislations around
surprise billing specifically. There were 16 overall provisions that the CMS put into place
around price transparency in general, one of which related to surprise billing. And then
you have these two with regards to price transparencies.
The last thing I'll say, though, important to note about the timing of the individual
clauses of this rule is that the requirements span from 2022 through 2024. The one that's
actually patient-facing, so the tool that Justin described, that would allow me as a
consumer to go to a website and actually look up not only the price, but also what my out-of-pocket
responsibility is. That's actually not required to be in place until 2024. One of the risks
here is how much will that clause get diluted between now and then, though the all sorts
of other agendas that come into play. So I think that's probably the most relevant part
for individual consumers, but that's the last piece to fall into place.
So given that timing, that, of course, begs the most important next question, which is,
how does this play out in practice, like actual implementation? Because again, this is something
that's announced. It's a press release. It's got news coverage. What is practically necessary
to actually get us there?
I think there are a couple of different angles that it's important to consider here. One
is the patient perspective, and the other is the health plan perspective. On the patient
side, it's something we've seen with other price transparencies efforts. The price is
certainly an important piece, but you've got to understand that people often equate price
with value and price with quality. So there's this whole parallel conversation about it's
not just enough to have the price alone, but really we need to pull in the data sets and
the pieces of information to guide folks on not only what is the best price, but where
you can get a good price for high quality health care service. And so it's one key portion
of the decision here.
The other side, which is arguably even more complex as the health plan side, and Julia
alluded to this early on, where there will undoubtedly be resistance. And we have seen
that with the hospital version of this, where various bodies took the rule to court. And
you add on top of that the oversight regulatory complexity here where there are various bodies
that oversee different types of health plans. So if I'm on a fully insured plan through
my employer and our smaller employer, that might be under the oversight of state insurance
regulators, where if I'm on a self insured plan through a larger employer, that might
be under the Department of Labor. And if I'm on a federal employee plan, that might be
the office personal management. So at the end of the day, we're hopeful that this can
have teeth and take hold, but it's not going to be a light switch. This is going to be
a longer process.
Yeah, it was a pretty big whiplash reaction from the hospital trade groups around the
prior hospital policies. It's interesting to read the response from AHIP, which is the
major trade group for the insurance industries, America's health insurance plans. You know,
they made a number of rebuttals against this rule. The central argument from them is that
price transparency would actually result in higher premiums and prices for consumers.
They also claim that the majority of health plans are already offering price transparency
tools, and therefore it's unnecessary to apply additional burden. And so to actually check
on that second claim, I actually went to my insurance website. There is a cost transparency
tool to their credit. However, when you search for actual procedures, every single result
basically gave me a message that said, cost is not available, please call the number back
of your card. So there is still a delta between the implementation of a tool versus the actual
content that's delivered through that tool.
The other kind of hilarious response that I remember from the hospital version of this
was from the AHA when they complained that complying with this would require spreadsheets
with hundreds of thousands of columns, and such files could crash most standard computer
systems. And again, so much of the efforts that CMS into their credit have made is like,
how do we just modernize the entire infrastructure of this industry? And if this is the way by
which we compel these parties to upgrade their version of Microsoft Excel, then so be it.
So it's really interesting, Julie, because you're basically describing this arc of technology
evolution where hospitals, we joke about them being on very old operating systems, but
most consumers are way past those systems. Forget even the evolution from old PCs, they're
in the mobile world where they are used to things that are very consumable, very accessible,
great UIs. So my question for you, how much do you really think that consumers actually
want to consume their healthcare information in this way once it's made machine readable,
especially because most people barely even understand their credit score. So I'm curious
for your thoughts on what's necessary or what needs to happen.
Yeah, I mean, it's a great question because there are so many players in this equation,
right? And consumers are certainly a critical and central and important one, but perhaps
the bigger profound impact that this type of rule has is actually around the behaviors
of how hospitals and insurance companies treat each other as trade partners. That actually
might be the place where we see the biggest impact. Will this actually change the way by
which insurance companies and providers negotiate price, which should, in theory, filter down
to the ultimate premiums that we pay and how the actual insurance products that we consume
are designed? Maybe that's where the bigger lever of influence is. And then maybe another
way to sort of look at this rule and something that came to mind as I was looking at it is
when you think about hospitals as kind of the entrenched incumbents versus the underdogs
in the market, like the independent practice groups, the ambulatory surgical centers, etc.
For the last several years, they have been polishing price. They've already been doing
a lot of this. And so as business floods away from these opaque hospitals into these more
transparent, lower acuity settings where their cost structure inherently is lower, that actually
to me is perhaps like a more powerful way to address this problem. It is to actually like
literally compete in the market by arming the more nimble players with a mandate that
they can actually implement. It might even mean more new hospitals, interestingly. Yeah.
And they'll be fundamentally different in structure than the hospitals of today. But
the other pieces too is this is what opens up the door to a lot of opportunity for builders
out there. There is invitation in this rule for third parties to come in and help to build
those products that folks would need to really make this actionable. What are the plan designs
that could be built on top of more transparency that would then incent people to make decisions
that are right for them? And importantly also, what is the research and policy that could
happen on top of all of this? And so I agree that the rule in isolation on its own doesn't
solve all the problem here, but it does invite the opportunity for the macro players to have
to adjust and also for there to be an ecosystem that's built up around it. It's interesting
to draw the analogies between this and other industries, price transparency and even like
dynamic pricing has been a thing for decades, whether it's e-commerce, whether it's the
travel industry that used to build software for the e-commerce industry in the early part
of my career. And there's entire companies who are dedicated to providing robust pricing
engines. You can build custom catalogs where you have all sorts of different permutations
per SKU as to how you price things. Obviously the most complex form of this is in the airline
industry where you have actual dynamic pricing that change in real time based on actual capacity
and whatnot. Amazon has hundreds of millions of SKUs. When you compare that to what the
provider and insurance companies will have to deal with, there are less than 20,000 CPT
codes. So CPT codes are the codes that dictate what services you can go for. If you just limit
that, for instance, to the shoppable services, you're talking about hundreds of codes and
there are roughly 6,000 hospitals in this country. And so even if you were to have a
single price per hospital for every possible service that's provided, you're talking about
like maybe 10 million lines of data. And it's embarrassing that we would, as an industry,
make an excuse that we couldn't handle that. So I do think that there's a lot to be said
about the opportunity for tech companies to enable these hospital systems to actually
implement that in a very cost-effective way because another argument from the industry
was claiming it's going to be millions of dollars to stand up a system that can produce
this kind of data file. That's absolutely not the case, just given the cost-effective
SAS type tooling that we now have available to us in other industries.
So one last question about what's real here is the whole point of all these dynamics is
to align incentives. And the whole reason we have this "shadowy system" as we've talked
about is that there is no transparency. And one of the reasons transparency matters is
that it leads to better incentive alignment. So what are some of the challenges when it
comes to aligning the incentives in this system to make this work?
Yeah, that's a great question. And I'd say the more complex side of the incentive puzzle
is really on the health plan side. The financial structure of a health plan is guided by this
concept called the medical loss ratio, where in its simplest form, they are regulated on
the basis of they have to spend a certain percentage of your premium dollar on your
care. It basically caps and creates a ceiling around what their profits and administrative
costs can be. And so even in an environment where you create more transparency, they might
not feel the incentive to guide you toward lower-cost options, because at the end of
the day, they have to return any of that access back to the consumer. It doesn't really drop
to their bottom line, but this ruling itself addresses some of that, where it enables payers
to take credit for some of those more informed, cost-driven decision-making on the patient
side and get credit against their MLR for that, against their medical loss ratio. And
so time will tell if it's enough to really align, but at least take strides in that direction.
I agree with everything Justin said with regards to how insurance companies may respond. I
think ultimately for us as consumers, the other holy grail outcome here is if hospitals
actually start to compete on actual value and actual service. Part of why they don't
do that today is because we don't even know the price. So there's no basis on which we
can even make an argument that you're not getting what you paid for. Sure, the price
matters, but if I'm paying a cheaper price for a crappier outcome, then it's all moot.
Okay, so bottom line it for me. What should our take away be on this transparency and
coverage final rule? In the long arduous march towards lowering the cost of our healthcare
delivery system while also increasing the improving value. This is one of many important
steps to get us towards that promised land where we actually do have something as close
as possible to efficient market dynamics between especially the insurance companies and hospitals.
It's also yet another reason why it's such a momentous era for digital health companies
in that they have always wanted to compete on quality, on customer service, on value
relative to price. And it's been the absence of a rational market that has really prevented
that. So this movement should hopefully be one important aspect of leveling the playing
field for all new entrants. Well, thank you so much you guys for joining this episode
of 16 minutes. Thanks guys. Thank you.
Podcast Summary
Key Points:
The new Transparency in Coverage Rules in Healthcare Pricing require disclosure of price and cost-sharing information upfront.
The rules aim to provide patients with accurate cost estimates, accessible price information, and standardized comparisons.
The rules shift focus to payers for transparency and understanding of negotiated prices and individual responsibilities.
Implementation of the rules spans from 2022 to 2024, with a focus on machine-readable files and patient-facing tools.
Challenges include resistance from industry players, concerns about premium increases, and the need to modernize technology for transparency.
Summary:
The latest Transparency in Coverage Rules in Healthcare Pricing mandate the disclosure of price and cost-sharing information upfront to participants, beneficiaries, and enrollees. The rules aim to provide patients with accurate cost estimates, accessible price information, and standardized comparisons, shifting the focus to payers for transparency. Implementation of the rules spans from 2022 to 2024, emphasizing machine-readable files and patient-facing tools.
Challenges include industry resistance, concerns about potential premium increases, and the need to modernize technology for effective transparency. The rules seek to address the complexity of healthcare costs and empower consumers to make informed decisions, ultimately aiming to reduce surprise bills and increase transparency in the healthcare pricing system.
FAQs
The rules require disclosing price and cost-sharing information, aiming for easy comparisons and competition.
It addresses ballooning healthcare costs and shifts focus to hospitals and insurance companies for negotiation transparency.
Price refers to charges to payers, while cost indicates out-of-pocket expenses for consumers, contributing to cost escalation.
While the rules aim to provide transparency, unforeseen costs may still arise, especially in emergency or non-shoppable services.
Challenges include patient perception of value, resistance from health plans, and regulatory complexities, making the process gradual and complex.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.